Related Experiment Video
Updated: Oct 10, 2026
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Prenatal cocaine exposure and child outcome: a model for the study of the infant at risk
1Department of Psychiatry and Human Behavior, Brown University School of Medicine, Providence, RI, USA.
Insights
Cocaine use during pregnancy poses significant risks to child development, necessitating focused research and policy. This review examines the effects on infants and informs public health strategies.
Area of Science:
- Perinatal health
- Developmental toxicology
- Public health policy
Background:
- Maternal cocaine use is a significant public health concern in the United States.
- The impact of prenatal cocaine exposure on infant development is a critical area of study.
- Understanding these effects is crucial for effective intervention and policy development.
Purpose of the Study:
- To review current knowledge on the effects of prenatal cocaine exposure on child development.
- To identify methodological challenges in studying drug-exposed infants.
- To discuss implications for public policy and treatment strategies.
Main Methods:
- Literature review and synthesis of existing research findings.
- Analysis of methodological issues in studies of drug-exposed infants.
- Examination of public policy and treatment considerations.
Main Results:
- Prenatal cocaine exposure presents complex challenges for infant development.
- Methodological limitations in research impact the understanding of long-term effects.
- Effective public policy and treatment require a comprehensive approach.
Conclusions:
- The drug-exposed infant serves as a model for understanding infants at risk.
- Further research is needed to address methodological issues and refine interventions.
- Informed public policy and targeted treatments are essential for mitigating negative outcomes.
Abstract:
The problem of cocaine use by pregnant women and the effects on the developing child has become major focus of research, treatment and public policy in the United States. The purpose of this article is to summarize our knowledge base in this area including methodological issues, discuss the drug exposed infant as a prototype of the infant at risk, and to consider issues that impact on public policy and treatment.
